-
Drug-eluting balloons in coronary interventions: the quiet revolution?Alfonso F, García-Guimaraes M, Navarrete G et al. -
Changes in high-sensitivity troponin after drug-coated balloon angioplasty for drug-eluting stent restenosisColleran R, Harada Y, Kufner S et al.
-
Treatment strategies for coronary in-stent restenosis: systematic review and hierarchical Bayesian network meta-analysis of 24 randomised trials and 4880 patientsGiacoppo D, Gargiulo G, Capodanno D et al.
-
Comparison of 2 Different Drug-Coated Balloons in In-Stent Restenosis: The RESTORE ISR China Randomized TrialYD Chen, L Gao, Q Qin et al.
-
Drug-coated balloon for treatment of de-novo coronary artery lesions in patients with high bleeding risk (DEBUT): a single-blind, randomised, non-inferiority trialRissanen TT, Uskela S, DEBUT trial investigators.
-
A sirolimus-eluting bioabsorbable polymer-coated stent (MiStent) versus an everolimus-eluting durable polymer stent (Xience) after percutaneous coronary intervention (DESSOLVE III): a randomised, single-blind, multicentre, non-inferiority, phase 3 trialde Winter RJ, Katagiri Y, Serruys PW et al.
-
Comparative efficacy of two paclitaxel-coated balloons with different excipient coatings in patients with coronary in-stent restenosis: A pooled analysis of the Intracoronary Stenting and Angiographic Results: Optimizing Treatment of Drug Eluting Stent In-Stent Restenosis 3 and 4 trialsColleran R, Joner M, ISAR-DESIRE 3 and ISAR-DESIRE 4 investigators
-
Therapeutic efficacy of paclitaxel-coated balloon for de novo coronary lesions with diameters larger than 2.8 mmYu X, Ji FS, Xu F et al.
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.
